CLPT 15.55 (+6.07%)
US18507C1036Medical Devices & InstrumentsMedical Devices

ClearPoint Neuro (CLPT) Stock Highlights

15.55 | +6.07%
2024-12-21 05:54:54
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The companys ClearPoint system, which is in commercial use in the United States, is used to perform minimally invasive surgical procedures in the brain and ClearTrace is used to perform minimally invasive surgical procedures in the heart. The companys products and product candidates include ClearPoint neuro system, MRI-guided drug delivery, and Thermal therapy system.

Statistics

Range Today
14.29 15.78
Volume Today 258.9K
Range 1 Year
5.11 17.47
Volume 1 Year 48.02M
Range 3 Year
4.05 17.47
Volume 3 Year 119.17M
Range 10 Year
1.33 58.4
Volume 10 Year 242.32M

Highlights

Market Capitalization 321.49M (small)
Floating Shares 25.24M
Current Price 15.55
Price To Earnings -17.86
Price To Revenue 12.52
Price To Book 13.56
Earnings Per Share -0.7
Payout Ratio 0%

Performance

Latest +6.07%
1 Month +41.75%
3 Months +26.73%
6 Months +196.19%
1 Year +134.54%
3 Years +40.09%
5 Years +238.04%
10 Years -54.26%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.